News for Mydecine Innovations Group Inc. (MYCO.NE)

Published at

Feb 7, 2024 11:04 PM

by financialpost.com

mixed

mixed

Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds

VANCOUVER, British Columbia, Feb. 07, 2024 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG)…

MYCOF MYCO.CN MYCO.NE

Read more →
Published at

Feb 2, 2024 10:07 PM

by financialpost.com

neutral

neutral

Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG)…

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Feb 2, 2024 10:06 PM

by marketscreener.com

mixed

mixed

Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 -- Mydecine Innovations Group Inc. , a forefront biotechnology company dedicated to revolutionizing mental health and addiction treatment, announces...

MYCOF MYCO.CN MYCO.NE

Read more →
Published at

Dec 18, 2023 8:02 AM

by financialpost.com

positive

positive

Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound

VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG)…

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Nov 28, 2023 10:09 PM

by financialpost.com

positive

positive

Mydecine Announces Update Regarding the Special Access Program

DENVER, Nov. 28, 2023 (GLOBE NEWSWIRE) —

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Nov 28, 2023 10:06 PM

by marketscreener.com

positive

positive

Mydecine Announces Update Regarding the Special Access Program

DENVER, Nov. 28, 2023 -- Mydecine Innovations Group Inc. a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health...

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Nov 17, 2023 8:20 PM

by investorideas.com

neutral

neutral

Canadian Securities Exchange Reports October 2023 Performance Figures

Toronto, Ontario - November 17, 2023 (Newsfile Corp.) (Investorideas.com Newswire) The Canadian Securities Exchange ("CSE" or "the Exchange") today announced ma...

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Nov 17, 2023 6:05 PM

by marketscreener.com

neutral

neutral

Canadian Securities Exchange Reports October 2023 Performance Figures

The Canadian Securities Exchange today announced market statistics for October 2023.October 2023 Operating StatisticsTrading volume of CSE-listed securities totaled 915 million shares;Trading value...

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Oct 31, 2023 7:02 AM

by marketscreener.com

positive

positive

Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements

VANCOUVER, British Columbia, Oct. 31, 2023 -- Mydecine Innovations Group Inc. a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Oct 31, 2023 7:00 AM

by financialpost.com

positive

positive

Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements

VANCOUVER, British Columbia, Oct. 31, 2023 (GLOBE NEWSWIRE) —

MYCOF MYCO.NE MYCO.CN

Read more →
Published at

Oct 12, 2023 8:01 AM

by marketscreener.com

mixed

mixed

Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK

VANCOUVER, British Columbia, Oct. 12, 2023 -- Mydecine Innovations Group, Inc. , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly...

MYCOF MYCO.NE MYCO.CN HEMP CBDS WEED.TO CGC

Read more →
Published at

Oct 10, 2023 8:00 AM

by financialpost.com

mixed

mixed

Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth Market in London, UK and First Day of Dealings

VANCOUVER, British Columbia, Oct. 10, 2023 (GLOBE NEWSWIRE) —

VCCTF MYCOF MYCO.NE MYCO.CN HEMP CBDS WEED.TO CGC

Read more →
Published at

Sep 23, 2022 4:47 PM

by benzinga.com

positive

positive

Will Cannabis Entrepreneurs Switch To Psychedelics? - Compass Pathways (NASDAQ:CMPS), Enveric Biosciences (NASDAQ:ENVB), Mind Medicine (NASDAQ:MNMD), Cybin (AMEX:CYBN)

The psychedelics space is heating up, and major players have taken notice.

TRUFF MYCOF MYCO.NE MYCO.CN MNMD MMEDF MMED.NE MMDWF MMDCF MMCWF HSTRF FTRPF FTRP.TO FTRP.CN FTRP ENVB CYBN CMPS

Read more →
Published at

Aug 31, 2022 1:01 AM

by benzinga.com

mixed

mixed

Common Stock (ENVB), KetamineOne Capital (KONEF), (MNMD), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC. (MYCOF), NeonMind Biosciences (NMDBF), (NUMIF) – World Class Leaders In Psychedelics For

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

NMDBF MYCOF ENTBF CYBN MYCO.NE MYCO.CN KONEF

Read more →